|
Market Closed -
NSE India S.E.
12:05:10 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 890.05 INR | -0.45% |
|
-3.78% | +26.75% |
| Market Cap | 7.32B 77.53M 66.71M 62.77M 57.34M 107M 108M 742M 288M 3.76B 291M 285M 12.1B | P/E 2024 |
45.4x | P/E 2025 | 45.4x |
|---|---|---|---|---|---|
| Enterprise Value | 7.28B 77.08M 66.32M 62.4M 57M 107M 107M 737M 286M 3.73B 289M 283M 12.03B | EV / Sales 2024 |
4.69x | EV / Sales 2025 | 2.12x |
| Free-Float |
24.75% | Yield 2024 |
0.09% | Yield 2025 | 0.07% |
| 1 day | -0.45% | ||
| 1 week | -3.78% | ||
| Current month | -1.05% | ||
| 1 month | +15.74% | ||
| 3 months | +26.57% | ||
| 6 months | +44.71% | ||
| Current year | +26.75% |
| 1 week | 866 | 921.95 | |
| 1 month | 815 | 987.5 | |
| Current year | 580 | 987.5 | |
| 1 year | 580 | 987.5 | |
| 3 years | 506.25 | 1,417.38 | |
| 5 years | 213.91 | 1,417.38 | |
| 10 years | 213.91 | 1,417.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 39 | 15/01/2023 | |
Bhavik Shah
DFI | Director of Finance/CFO | - | 08/07/2026 |
| Compliance Officer | - | 05/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 39 | 20/09/2015 | |
| Chairman | 41 | 20/09/2015 | |
| Director/Board Member | 38 | 20/09/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.45% | -3.78% | +5.85% | +65.87% | 110M | ||
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | ||
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | ||
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | ||
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | ||
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | ||
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | ||
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | ||
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | ||
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | ||
| Average | -0.88% | +0.60% | +26.37% | +53.68% | 367.85B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.13B 22.54M 19.4M 18.25M 16.67M 31.19M 31.28M 216M 83.7M 1.09B 84.66M 82.81M 3.52B | 6.2B 65.71M 56.54M 53.2M 48.59M 90.9M 91.15M 629M 244M 3.18B 247M 241M 10.25B |
| Net income | 215M 2.28M 1.96M 1.85M 1.69M 3.16M 3.16M 21.82M 8.47M 110M 8.57M 8.38M 356M | 291M 3.08M 2.65M 2.49M 2.28M 4.26M 4.27M 29.46M 11.43M 149M 11.56M 11.31M 480M |
| Net Debt | -178M -1.89M -1.62M -1.53M -1.39M -2.61M -2.62M -18.03M -7M -91.31M -7.08M -6.92M -294M | -42.9M -454K -391K -368K -336K -629K -630K -4.35M -1.69M -22.01M -1.71M -1.67M -70.91M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | ₹890.05 | -0.45% | 3,000 |
| 03/09/26 | ₹894.10 | +0.99% | 8,600 |
| 02/09/26 | ₹885.30 | +2.16% | 3,400 |
| 01/09/26 | ₹866.60 | -3.65% | 3,800 |
| 31/08/26 | ₹899.45 | -2.76% | 7,000 |
- Stock Market
- Stocks
- REMUS Stock
Select your edition
All financial news and data tailored to specific country editions
















